Bryan Harder

Brusatol overcomes chemoresistance through inhibition of protein translation

Bryan Harder, Tian Wang, James J. La Clair et al. · Molecular Carcinogenesis · 2016 · 131 citations

Medicine, Oncology, Pharmacology +17

Oxidative stress, mammospheres and Nrf2–new implication for breast cancer therapy?

Tongde Wu, Bryan Harder, Pak Kin Wong et al. · Molecular Carcinogenesis · 2014 · 116 citations · Full text

Medicine, Cancer Biology, Oncology +17

Reduced Nrf2 expression mediates the decline in neural stem cell function during a critical middle‐age period

Mandi J. Corenblum, Sneha Ray, Quentin W. Remley et al. · Aging Cell · 2016 · 100 citations · Full text

Life Sciences, Neurobiology, Neuroscience +12

Pacritinib is a potent ACVR1 inhibitor with significant anemia benefit in patients with myelofibrosis

Stephen T. Oh, Ruben A. Mesa, Claire Harrison et al. · Blood Advances · 2023 · 73 citations · Full text

Medicine, Pharmacology, Pharmacotherapy +5

Low-level arsenic causes proteotoxic stress and not oxidative stress

Matthew Dodson, Montserrat Rojo de la Vega, Bryan Harder et al. · Toxicology and Applied Pharmacology · 2018 · 58 citations

Pharmacy, Biochemistry, Toxicology +14